
A Family Cancer Diagnosis Helped Spark a Portuguese Biotech Deal With BioNTech
Dr. Dereck Mush, MD, MBABioNTech is a biotechnology company that develops immunotherapies for cancer and infectious diseases, including mRNA medicines and vaccines.
Checked 14 November 2026. Source
BioNTech was founded in 2008 in Mainz, Germany, where it is still headquartered. With Pfizer it developed Comirnaty, an mRNA vaccine against COVID-19. Its main focus is oncology, with programs that include individualized mRNA cancer immunotherapies, immunomodulators such as bispecific antibodies, antibody drug conjugates, and cell therapies. BioNTech runs research and manufacturing sites in Germany and other countries and partners with drug companies and academic groups on discovery and development. Its shares trade on the Nasdaq.
Leadership as of 14 November 2026.
CEO and co-founder
Founder
Founder

Dr. Dereck Mush, MD, MBARelated companies